Search

Selected EMA news

January 2025New medicines recommended for approval
Rytelo (imetelstat sodium) - orphan
Treatment of anemia (low levels of red blood cells)
Zefylti (filgrastim) – biosimilar
Treatment of neutropenia (low level of white blood cells) in patients having chemotherapy or a bone marrow transplant
New…

Read more

Genetic Predisposition to Blood Cancer (Rare diseases)

The objectives of the group are:

Share and extend clinical knowledge on the diagnosis and treatment of hematologic malignancies with germline predisposition.

Read more

Chronic Myeloid Leukemia

The objective of this SWG is the cure of Chronic Myeloid Leukemia (CML) by cooperative research.

Read more

Previous exams

2024 exam

The most recent European Hematology Exam took place on June 13, 2024. In total, 244 candidates took the exam at 15 locations.

Read more

EHA SIOPe Pediatric Extended Syllabus

In collaboration with the European Society for Paediatric Oncology (SIOPe), EHA has developed a pediatric hematology syllabus as an addendum to the adult hematology syllabus.

Read more

Childcare services

EHA is pleased to offer complimentary professional childcare services for registered Congress participants’ children throughout the duration of the EHA2025 Congress.

Read more

Presidential Speakers

Promising crucial developments in the field of hematology, the speakers and presentation topics of the EHA2025 Presidential Session speakers are now available.  

Friday, June 13, 2025 - Presidential Session I

Immunotherapy (TCR related)

Prof.

Read more

EU calls for proposal 2023

IntroductionHorizon Europe is the research and innovation programme of the EU for the period 2021-2027. The programme facilitates research collaboration and strengthens the impact of R&I in developing, supporting and implementing EU policies while tackling global challenges.

Read more

SWG Educational Activities

General meetings in 2023Meetings to discuss the progress and management of collaborations within the European networks.

Read more